Methyl (4-cyano-3-(trifluoromethyl)phenyl)carbamodithioate

Methyl (4-cyano-3-(trifluoromethyl)phenyl)carbamodithioate or Methyl (4-cyano-3-(trifluoromethyl)phenyl)carbamodithioate, is an impurity of Enzalutamide, enzalutamide is a potent androgen receptor antagonist, Enzalutamide binding to the ligand-binding pocket, which is used in the treatment of advanced prostate cancer.

Additional information

Catalogue No.

VE009236

CAS No.

N/A

Molecular Formula

C10H7F3N2S2

Molecular Weight

276.30 g/mol

IUPAC Name

Methyl (4-cyano-3-(trifluoromethyl)phenyl)carbamodithioate

References

Linder, S., van der Poel, H. G., Bergman, A. M., Zwart, W., & Prekovic, S. (2019). Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond. Endocrine-Related Cancer, 26(1), R31–R52. https://doi.org/10.1530/erc-18-0289

Status

In-stock